TRIB
Trinity Biotech
TRIB
TRIB
29 hedge funds and large institutions have $16.6M invested in Trinity Biotech in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $20.3M → $16.6M (-$3.67M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
29
Holding in Top 10
–
Calls
$586K
Puts
$426K
Top Buyers
| 1 | +$1.21M | |
| 2 | +$250K | |
| 3 | +$112K | |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
+$55.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$34K |
Top Sellers
| 1 | -$280K | |
| 2 | -$222K | |
| 3 | -$137K | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$106K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$103K |